Chem Shift validation: AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR27373
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Tong, Michael; Pelton, Jeff; Gill, Michelle; Zhang, Weibing; Picart, Francis; Seeliger, Markus. "Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites" Nat. Commun. 2160, 1-15 (2017).
PubMed: 29255153
Assembly members:
Src_kinase_domain, polymer, 286 residues, 32688.5875 Da.
entity_1N1, non-polymer, 488.006 Da.
Natural source: Common Name: Chicken Taxonomy ID: 9031 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Gallus gallus
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: modified pET
Entity Sequences (FASTA):
Src_kinase_domain: GHMQTQGLAKDAWEIPRESL
RLEVKLGQGCFGEVWMGTWN
GTTRVAIKTLKPGTMSPEAF
LQEAQVMKKLRHEKLVQLYA
VVSEEPIYIVTEYMSKGSLL
DFLKGEMGKYLRLPQLVDMA
AQIASGMAYVERMNYVHRDL
RAANILVGENLVCKVADFGL
ARLIEDNEYTARQGAKFPIK
WTAPEAALYGRFTIKSDVWS
FGILLTELTTKGRVPYPGMV
NREVLDQVERGYRMPCPPEC
PESLHDLMCQCWRKDPEERP
TFEYLQAFLEDYFTSTEPQY
QPGENL
Data type | Count |
13C chemical shifts | 719 |
15N chemical shifts | 239 |
1H chemical shifts | 239 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | Src kinase domain | 1 |
2 | dasatinib | 2 |
Entity 1, Src kinase domain 286 residues - 32688.5875 Da.
1 | GLY | HIS | MET | GLN | THR | GLN | GLY | LEU | ALA | LYS | ||||
2 | ASP | ALA | TRP | GLU | ILE | PRO | ARG | GLU | SER | LEU | ||||
3 | ARG | LEU | GLU | VAL | LYS | LEU | GLY | GLN | GLY | CYS | ||||
4 | PHE | GLY | GLU | VAL | TRP | MET | GLY | THR | TRP | ASN | ||||
5 | GLY | THR | THR | ARG | VAL | ALA | ILE | LYS | THR | LEU | ||||
6 | LYS | PRO | GLY | THR | MET | SER | PRO | GLU | ALA | PHE | ||||
7 | LEU | GLN | GLU | ALA | GLN | VAL | MET | LYS | LYS | LEU | ||||
8 | ARG | HIS | GLU | LYS | LEU | VAL | GLN | LEU | TYR | ALA | ||||
9 | VAL | VAL | SER | GLU | GLU | PRO | ILE | TYR | ILE | VAL | ||||
10 | THR | GLU | TYR | MET | SER | LYS | GLY | SER | LEU | LEU | ||||
11 | ASP | PHE | LEU | LYS | GLY | GLU | MET | GLY | LYS | TYR | ||||
12 | LEU | ARG | LEU | PRO | GLN | LEU | VAL | ASP | MET | ALA | ||||
13 | ALA | GLN | ILE | ALA | SER | GLY | MET | ALA | TYR | VAL | ||||
14 | GLU | ARG | MET | ASN | TYR | VAL | HIS | ARG | ASP | LEU | ||||
15 | ARG | ALA | ALA | ASN | ILE | LEU | VAL | GLY | GLU | ASN | ||||
16 | LEU | VAL | CYS | LYS | VAL | ALA | ASP | PHE | GLY | LEU | ||||
17 | ALA | ARG | LEU | ILE | GLU | ASP | ASN | GLU | TYR | THR | ||||
18 | ALA | ARG | GLN | GLY | ALA | LYS | PHE | PRO | ILE | LYS | ||||
19 | TRP | THR | ALA | PRO | GLU | ALA | ALA | LEU | TYR | GLY | ||||
20 | ARG | PHE | THR | ILE | LYS | SER | ASP | VAL | TRP | SER | ||||
21 | PHE | GLY | ILE | LEU | LEU | THR | GLU | LEU | THR | THR | ||||
22 | LYS | GLY | ARG | VAL | PRO | TYR | PRO | GLY | MET | VAL | ||||
23 | ASN | ARG | GLU | VAL | LEU | ASP | GLN | VAL | GLU | ARG | ||||
24 | GLY | TYR | ARG | MET | PRO | CYS | PRO | PRO | GLU | CYS | ||||
25 | PRO | GLU | SER | LEU | HIS | ASP | LEU | MET | CYS | GLN | ||||
26 | CYS | TRP | ARG | LYS | ASP | PRO | GLU | GLU | ARG | PRO | ||||
27 | THR | PHE | GLU | TYR | LEU | GLN | ALA | PHE | LEU | GLU | ||||
28 | ASP | TYR | PHE | THR | SER | THR | GLU | PRO | GLN | TYR | ||||
29 | GLN | PRO | GLY | GLU | ASN | LEU |
Entity 2, dasatinib - C22 H26 Cl N7 O2 S - 488.006 Da.
1 | 1N1 |
pSrcKD_15N-Phe-dasatinib: Src kinase domain, [U-15N]-Phe, 0.2 mM; dasatinib 0.5 mM; Tris 20.0 mM; MES 100.0 mM; NaCl 250.0 mM; DTT 10.0 mM
pSrcKD_15N-Tyr-dasatinib: Src kinase domain, [U-15N]-Tyr, 0.2 mM; dasatinib 0.5 mM; Tris 20.0 mM; MES 100.0 mM; NaCl 250.0 mM; DTT 10.0 mM
pSrcKD_15N-Val-dasatinib: Src kinase domain, [U-15N]-Val, 0.2 mM; dasatinib 0.5 mM; Tris 20.0 mM; MES 100.0 mM; NaCl 250.0 mM; DTT 10.0 mM
pSrcKD_2H_15N_13C_dasatinib: Src kinase domain, [U-100% 13C; U-100% 15N; U-80% 2H], 0.2 mM; dasatinib 0.5 mM; Tris 20.0 mM; MES 100.0 mM; NaCl 250.0 mM; DTT 10.0 mM
CondSet1: ionic strength: 0.250 M; pH: 5.800; pressure: 1.000 atm; temperature: 303.000 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N HSQC/HMQC | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
3D HN(CO)CA | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
3D HNCO | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
HNcaCO | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
3D HNCA | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
3D HNCACB | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
H[N[co[{CA|ca[C]}]]] | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
3D 1H-15N NOESY | pSrcKD_2H_15N_13C_dasatinib | isotropic | CondSet1 |
2D 1H-15N HSQC/HMQC | pSrcKD_15N-Phe-dasatinib | isotropic | CondSet1 |
2D 1H-15N HSQC/HMQC | pSrcKD_15N-Tyr-dasatinib | isotropic | CondSet1 |
2D 1H-15N HSQC/HMQC | pSrcKD_15N-Val-dasatinib | isotropic | CondSet1 |
CcpNmr_Analysis v2.4.2, CCPN - chemical shift assignment
NMRpipe vunknown, Delaglio et al - data processing
TOPSPIN vunknown, Bruker - data aqcuisition, processing
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks